|
Disease |
|
|
|
Detail |
hsa-miR-155 |
|
Unspecified |
BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. |
2005 |
|
|
|
|
|
|
hsa-miR-135a |
|
Causal |
Regulation of JAK2 by miR-135a: prognostic impact in classical Hodgkin lymphoma. |
2009 |
|
|
|
|
|
|
hsa-miR-200a |
|
Unspecified |
Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77 B-cells reveals a distinct subset of differentially expressed miRNAs |
2009 |
|
|
|
|
|
|
hsa-miR-520a |
|
Unspecified |
Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77 B-cells reveals a distinct subset of differentially expressed miRNAs |
2009 |
|
|
|
|
|
|
hsa-miR-614 |
|
Unspecified |
Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77 B-cells reveals a distinct subset of differentially expressed miRNAs |
2009 |
|
|
|
|
|
|
hsa-miR-140 |
|
Unspecified |
Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77 B-cells reveals a distinct subset of differentially expressed miRNAs |
2009 |
|
|
|
|
|
|
hsa-miR-155 |
|
Unspecified |
Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77 B-cells reveals a distinct subset of differentially expressed miRNAs |
2009 |
|
|
|
|
|
|
hsa-miR-16 |
|
Unspecified |
Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77 B-cells reveals a distinct subset of differentially expressed miRNAs |
2009 |
|
|
|
|
|
|
hsa-miR-186 |
|
Unspecified |
Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77 B-cells reveals a distinct subset of differentially expressed miRNAs |
2009 |
|
|
|
|
|
|
hsa-miR-18a |
|
Unspecified |
Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77 B-cells reveals a distinct subset of differentially expressed miRNAs |
2009 |
|
|
|
|
|
|
hsa-miR-196a |
|
Unspecified |
Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77 B-cells reveals a distinct subset of differentially expressed miRNAs |
2009 |
|
|
|
|
|
|
hsa-miR-20a |
|
Unspecified |
Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77 B-cells reveals a distinct subset of differentially expressed miRNAs |
2009 |
|
|
|
|
|
|
hsa-miR-21 |
|
Unspecified |
Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77 B-cells reveals a distinct subset of differentially expressed miRNAs |
2009 |
|
|
|
|
|
|
hsa-miR-30a-5p |
|
Unspecified |
Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77 B-cells reveals a distinct subset of differentially expressed miRNAs |
2009 |
|
|
|
|
|
|
hsa-miR-30b |
|
Unspecified |
Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77 B-cells reveals a distinct subset of differentially expressed miRNAs |
2009 |
|
|
|
|
|
|
hsa-miR-374 |
|
Unspecified |
Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77 B-cells reveals a distinct subset of differentially expressed miRNAs |
2009 |
|
|
|
|
|
|
hsa-miR-9 |
|
Unspecified |
Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77 B-cells reveals a distinct subset of differentially expressed miRNAs |
2009 |
|
|
|
|
|
|
hsa-let-7a |
|
Causal |
MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas. |
2008 |
|
|
|
|
|
|
hsa-miR-9 |
|
Causal |
MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas. |
2008 |
|
|
|
|
|
|